内容

目次

Part I: Ethics and Oversight 1. F. Lucivero & T. Swierstra & M. Boenink, Assessing Expectations: Towards a Toolbox for an Ethics of Emerging Technologies Nanoethics, 5, 129-141 (2011) 2. B. Hofmann, Why Ethics should be part of Health Technology Assessment, International Journal of Technology Assessment in Health Care, 24:4, 423-429 (2008) 3. D.B. Kramer, Shuai Xu, and Aaron S. Kesselheim, Regulation of Medical Devices in the United States and European Union, NEJM, 366:9, 848-855 (2012) 4. G. D. Curfman, and R. F. Redberg, Medical Devices — Balancing Regulation and Innovation, NEJM, 365:11, 975-977 (2011) 5. Emily C. Feinstein, Arthur Caplan, Jonathan D. Moreno and Ilene Albala-Reicher, The Ethics of off-LabelUse of FDA-Approved Products, chapter in Off-Label Communications: A Guide to Sales and Marketing Compliance (4th Edition), published by Food and Drug Law Institute, 2014 pp. 49-77 Part II: Preventive 6. M.J. Young, D.A. Sisti, H Rimon-Greenspan, J.L. Schwartz & A.L. Caplan, Immune to addiction: the ethical dimensions of vaccines against substance abuse, Nature Immunology 13:6, 521-524 (2012). 7. A.L. Bredenoord, G. Pennings and G. de Wert, Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues, Human Reproduction Update, 14:6, 669–678, (2008). 8. R Sparrow, L Sparrow, In the hands of machines? The future of aged care, Minds and Machines, 16, 141-161 (2006). 9. S. Bull, L.T. Breslin, E.E. Wright, S.R. Black, D Levine, J.S. Santelli, Case Study: An Ethics Case Study of HIV Prevention Research on Facebook: The Just/Us Study, Journal of Pediatric Psychology, 36:10, 1082-1092 (November/December 2011) 10. J.Timmermans & Y. Zhao & J. v.d. Hoven, Ethics and Nanopharmacy: Value Sensitive Design of New Drugs, Nanoethics, 5, 269–283 (2011). Part III: Diagnostic 11. B.J. Healey, D. Kopen, J Smith, Physicians, Defensive Medicine, and Ethics, Academy of Health Care Management Journal, 7:1, 59-78 (2011). 12. Juengst, Eric T., Michael A. Flatt, and Richard A. Settersten. Personalized genomic medicine and the rhetoric of empowerment., Hastings Center Report 42, no. 5 (2012): 34-40. 13. Tabor, Holly K., Jeffrey C. Murray, Hilary S. Gammill, Jacob O. Kitzman, Matthew W. Snyder, Mario Ventura, Alexandra P. Lewis et al. Non-invasive fetal genome sequencing: opportunities and challenges, American journal of medical genetics. Part A 158, no. 10 (2012): 2382. 14. Jox, Ralf J., James L. Bernat, Steven Laureys, and Eric Racine. "Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions." The Lancet Neurology 11, no. 8 (2012): 732-738. Part IV: Treatment Monitoring and Medical Information 15. R. Steinbrook, Personally Controlled Online Health Data - The Next Big Thing in Medical Care?, NEJM 358:16, 1653-1656 (2008). 16. Ossorio, Pilar N. "The Ethics of Translating High‐Throughput Science into Clinical Practice." Hastings Center Report 44, no. 5 (2014): 8-9. 17. E. Palm, Who Cares? Moral Obligations in Formal and Informal Care Provision in the Light of ICT-Based Home Care, Health Care Analysis 21, 171–188 (2013). 18. E.H. W. Kluge, Ethical and legal challenges for health telematics in a global world: Telehealth and the technological imperative, International Journal of Medical Informatics, 80, e1-e5 (2011). 19. Hoffman, Sharona, and Andy Podgurski. "Big bad data: law, public health, and biomedical databases." The Journal of Law, Medicine & Ethics 41, no. s1 (2013): 56-60. Part V: Therapeutic 20. M. Miyasaka, S.Sasaki, M. Tanaka, J. Kikunaga, Use of Brain-Machine Interfaces as Prosthetic Devices: An Ethical Analysis, Journal of Philosophy and Ethics in Health Care and Medicine, 6, 29-38 (2012). 21. R. Grant, C. Halpern, G. Baltuch, J. O’reardon, A. Caplan, Ethical considerations in deep brain stimulation for psychiatric illness, Journal of Clinical Neuroscience, 21, 1-5 (2014). 22. J. Dixon, J. Logue, P. Komesaroff, Promises and Ethical Pitfalls of Surgical Innovation: the Case of Bariatric Surgery, Obesity Surgery, 23, 1698-1702, (2013). 23. P. McCormack, S. Woods, A. Aartsma-Rus, L. Hagger, A. Herczegfalvi, E. Heslop, J. Irwin, J. Kirschner, P. Moeschen, F. Muntoni, M. Ouillade, J. Rahbek, C. Rehmann-Sutter, F. Rouault, T. Sejersen, E. Vroom, V. Straub, K. Bushby, A. Ferlini, Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: "Translating" the Translational , PLOS Currents Muscular Dystrophy, Edition 1 (2013). doi: 10.1371/currents.md.f90b49429fa814bd26c5b22b13d773ec. 24. Jeremy Sugarman, Questions Concerning the Clinical Translation of Cell-Based Interventions under an Innovation Pathway, Journal of Law Medicine and Ethics, 40:4, 945-950 (Winter 2012). 25. Fa-Ming Chen, Yi-Min Zhao, Yan Jin, Songtao Shi, Prospects for Translational Regenerative Medicine, Biotechnology Advances, 30, 658-672 (2012). 26. K. Reid, S. Greene, Diagnosis and treatment of temporomandibular disorders: an ethical analysis of current practices, Journal of Oral Rehabilitation 40, 546-561 (2013). Part VI: Rescue and End-of-Life 27. S. Badylak, D. Weiss, A. Caplan, P. Macchiarini, Engineered Whole Organs and Complex Tissues, The Lancet, 379, 1-10 (2012). 28. D. Abrams, K. Prager, C. Blinderman, K. Burkart, D. Brodie, Ethical Dilemmas Encountered With the Use of Extracorporeal Membrane Oxygenation in Adults, CHEST 145:4, 876-882 (2014). 29. M Gysels, N Evans, A Menaca, E Andrew, F Toscani, et al, Culture and End of Life Care: A Scoping Exercise in Seven European Countries, PLoS ONE, 7:4, 1-16 (2012). 30. D. Sulmasy. Within You / Without You: Biotechnology, Ontology, and Ethics, Journal of General Internal Medicine, 23:Suppl 1, 69-72 (2007). 31. J. Guerra González, Xenotransplantation, Humana Press, 281-305 (2012). 32. K. Swetz, J. Keith Mansel, Ethical Issues and Palliative Care in the Cardiovascular Intensive Care Unit, Cardiology Clinics 31, 657-668 (2013). Part VII: Normalization and Enhancement 33. Camporesi, Silvia, and Michael J. McNamee. "Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance enhancing technology?."Life Sciences Society and Policy 8, no. 1 (2012): 20. 34. A. Frank, Emily’s Scars: Surgical Shapings, Technoluxe, and Bioethics in Erik Parens, Ed., Surgically Shaping Children (Johns Hopkins UP) p. 68-89 35. Tom Humphries, Poorna Kushalnagar, Gaurav Mathur, Donna Jo Napoli, Carol Padden, Christian Rathmann, and Scott Smith, "Cochlear Implants and the Right to Language: Ethical Considerations, the Ideal Situation, and Practical Measures Toward Reaching the Ideal," Cochlear Implant Research Updates, Dr. Cila Umat (Ed.) p.193-212 (2012), ISBN: 978-953-51-0582-4. 36. Catsanos, Ruby, Wendy Rogers, and Mianna Lotz. "The ethics of uterus transplantation." Bioethics 27, no. 2 (2013): 65-73. 37. F. Coeytaux, M. Darnovsky, S.B. Fogel, Assisted reproduction and choice in the biotech age: recommendations for a way forward, Contraception, 83, 1-4 (2011). 38. Gems, David. "Tragedy and delight: the ethics of decelerated ageing."Philosophical transactions of the royal society B: Biological Sciences 366, no. 1561 (2011): 108-112. 39. Fröding, Barbro Elisabeth Esmeralda. "Cognitive enhancement, virtue ethics and the good life." Neuroethics 4, no. 3 (2011): 223-234.